Payment Type: | T/T,L/C |
---|
Model No.: 1195768-06-9
Brand: CONBOTTPHARM
Packaging: AS Required
Productivity: Customized
Transportation: Ocean,Air
Place of Origin: CHINA
Supply Ability: Commercial
Certificate: DOCUMENT SUPPORT
Payment Type: T/T,L/C
1195768-06-9,High Quality Dabrafenib Mesylate
We have rich experience in making dabrafenib mesylate Cas 1195768-06-9 Dabrafenib Mesylate manufacturers and suppliers in China. These high quality products are formulated by adopting quality methods and using well-tested ingredients that are procured from the certified vendors of the market. We offer these products in proper packaging of diverse quantity to meet assorted requirements of the clients.
Thera. Category: Anti- cancer
Cas No.: 1195768-06-9
Synonym: Dabrafenib Mesylate(GSK-2118436B);Dabrafenib Mesylate;GSK 2118436 Mesylate;GSK 2118436B;GSK2118436 Mesylate;GSK-2118436 Mesylate;Dabrafenib Mesylate (API);GSK 2118436 methanesulfonate salt
Molecular Formula:C24H24F3N5O5S3
Molecular Weight: 615.6680696
Assay: ≥97.%
Packing: Export worthy packing
Material Safety Data Sheet: Available on request
Usage: Dabrafenib, also known as GSK2118436, is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. On May 29, 2013, FDA approved this drug.
Related Intermediates :
1. CAS 630-22-8,2,2,2-Trimethylthioacetamide
2. CAS 914223-43-1,3-AMINO-2-FLUOROBENZOIC ACID
Product Categories : Inhibitors > BRAF Inhibitors